Laddar...
5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report
BACKGROUND: The loss of CD20 protein expression after a rituximab-containing regimen is one of the resistance mechanisms in non-Hodgkin's lymphoma. Recently, it was reported that 5-azacitidine administration upregulates the expression of CD20 in CD20-negative B-cell acute lymphoblastic leukemia...
Sparad:
| I publikationen: | J Med Case Rep |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4739428/ https://ncbi.nlm.nih.gov/pubmed/26838941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0809-7 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|